Cipla shares rose as much as 8.7 per cent on Tuesday after the drugmaker launched a generic version of GlaxoSmithKline's anti-asthma inhaler Advair in Germany and Sweden. Cipla is the first company to launch a generic version of the inhaler in these ... NDTV Profit, 13 hours ago
By Zeba Siddiqui MUMBAI (Reuters) - Ipca Laboratories Ltd has voluntarily halted shipments to the United States from one of its drug ingredient manufacturing plants after the U.S. Food and Drug Administration found violations of standard production practices ...Sify, 1 month ago India's Ipca halts U.S. shipments from plant after FDA finds violations Yahoo! Finance, 1 month ago Ipca Halts U.S. Shipments From Plant After FDA Finds Violations Medscape, 1 month ago UPDATE 2-India's Ipca halts U.S. shipments from plant after FDA finds violations Reuters India, 1 month ago
Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its ...The Financial Chronicle, 2 months ago
on your WebpageAdd Widget >Get your members hooked!